/cloudfront-us-east-2.images.arcpublishing.com/reuters/Q6C4KO7PNJIKFIBS3ZOGAYGHPE.jpg)
The U.S. Centers for Disease Control and Prevention said it will prioritize its public health response in a revamp of its structure after months of criticism over its handling of the COVID-19 and monkeypox pandemics.
A briefing document provided by the agency on Wednesday said an external report into its response found public guidance had caused confusion, while important information were sometimes released too late to inform federal decisions.
CDC Director Rochelle Walensky said in response the agency was undertaking a series of changes designed to make it more nimble at responding, quicker at providing data and less focused on publishing fully vetted scientific papers.
A federal judge officially approved drug maker Purdue Pharma’s latest deal to settle thousands of lawsuits...
This fall, multiple states including Maryland, Virginia, Tennessee and Wisconsin have reported outbreaks of hand, foot...
A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly...
